annual current liabilities:
$994.10M-$60.98M(-5.78%)Summary
- As of today (May 29, 2025), CRL annual total current liabilities is $994.10 million, with the most recent change of -$60.98 million (-5.78%) on December 28, 2024.
- During the last 3 years, CRL annual current liabilities has fallen by -$39.08 million (-3.78%).
- CRL annual current liabilities is now -8.93% below its all-time high of $1.09 billion, reached on December 31, 2022.
Performance
CRL Current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly current liabilities:
$1.05B+$56.95M(+5.73%)Summary
- As of today (May 29, 2025), CRL quarterly total current liabilities is $1.05 billion, with the most recent change of +$56.95 million (+5.73%) on March 29, 2025.
- Over the past year, CRL quarterly current liabilities has increased by +$96.25 million (+10.08%).
- CRL quarterly current liabilities is now -3.71% below its all-time high of $1.09 billion, reached on December 31, 2022.
Performance
CRL quarterly current liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Current liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CRL Current liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.8% | +10.1% |
| 3 y3 years | -3.8% | +5.8% |
| 5 y5 years | +40.0% | +52.1% |
CRL Current liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.9% | at low | -3.7% | +10.9% |
| 5 y | 5-year | -8.9% | +40.0% | -3.7% | +52.1% |
| alltime | all time | -8.9% | +1518.5% | -3.7% | +1635.8% |
CRL Current liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $1.05B(+5.7%) |
| Dec 2024 | $994.10M(-5.8%) | $994.10M(-1.8%) |
| Sep 2024 | - | $1.01B(+6.8%) |
| Jun 2024 | - | $947.52M(-0.8%) |
| Mar 2024 | - | $954.81M(-9.5%) |
| Dec 2023 | $1.06B(-3.3%) | $1.06B(+6.2%) |
| Sep 2023 | - | $993.82M(-1.4%) |
| Jun 2023 | - | $1.01B(+2.7%) |
| Mar 2023 | - | $981.39M(-10.1%) |
| Dec 2022 | $1.09B(+5.7%) | $1.09B(+7.6%) |
| Sep 2022 | - | $1.01B(-3.2%) |
| Jun 2022 | - | $1.05B(+5.5%) |
| Mar 2022 | - | $993.84M(-3.8%) |
| Dec 2021 | $1.03B(+23.0%) | $1.03B(+5.0%) |
| Sep 2021 | - | $983.75M(+5.8%) |
| Jun 2021 | - | $929.61M(+15.7%) |
| Mar 2021 | - | $803.38M(-4.3%) |
| Dec 2020 | $839.75M(+18.2%) | $839.75M(+6.7%) |
| Sep 2020 | - | $787.01M(+8.1%) |
| Jun 2020 | - | $727.94M(+5.4%) |
| Mar 2020 | - | $690.90M(-2.7%) |
| Dec 2019 | $710.18M(+27.2%) | $710.18M(+4.2%) |
| Sep 2019 | - | $681.65M(+7.2%) |
| Jun 2019 | - | $635.60M(+20.0%) |
| Mar 2019 | - | $529.76M(-5.1%) |
| Dec 2018 | $558.22M(+20.4%) | $558.22M(+3.5%) |
| Sep 2018 | - | $539.60M(+4.1%) |
| Jun 2018 | - | $518.14M(+27.3%) |
| Mar 2018 | - | $407.10M(-12.2%) |
| Dec 2017 | $463.50M(+7.9%) | $463.50M(+11.5%) |
| Sep 2017 | - | $415.75M(-2.0%) |
| Jun 2017 | - | $424.07M(+10.6%) |
| Mar 2017 | - | $383.37M(-10.8%) |
| Dec 2016 | $429.59M(+37.8%) | $429.59M(+4.3%) |
| Sep 2016 | - | $412.05M(-0.3%) |
| Jun 2016 | - | $413.39M(+33.4%) |
| Mar 2016 | - | $309.99M(-0.6%) |
| Dec 2015 | $311.76M(+5.8%) | $311.76M(-0.7%) |
| Sep 2015 | - | $314.10M(+13.6%) |
| Jun 2015 | - | $276.53M(+2.2%) |
| Mar 2015 | - | $270.49M(-8.2%) |
| Dec 2014 | $294.69M(+19.3%) | $294.69M(+4.1%) |
| Sep 2014 | - | $283.08M(+4.2%) |
| Jun 2014 | - | $271.65M(+13.5%) |
| Mar 2014 | - | $239.32M(-3.1%) |
| Dec 2013 | $247.03M(-27.8%) | $247.03M(+5.0%) |
| Sep 2013 | - | $235.17M(+4.1%) |
| Jun 2013 | - | $225.85M(-31.7%) |
| Mar 2013 | - | $330.81M(-3.3%) |
| Dec 2012 | $342.25M | $342.25M(+5.2%) |
| Sep 2012 | - | $325.24M(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2012 | - | $328.13M(+46.6%) |
| Mar 2012 | - | $223.84M(+3.2%) |
| Dec 2011 | $216.80M(-16.5%) | $216.80M(-3.1%) |
| Sep 2011 | - | $223.84M(-19.2%) |
| Jun 2011 | - | $277.10M(-10.0%) |
| Mar 2011 | - | $307.81M(+18.5%) |
| Dec 2010 | $259.78M(+4.0%) | $259.78M(+9.4%) |
| Sep 2010 | - | $237.38M(-3.5%) |
| Jun 2010 | - | $246.06M(-0.5%) |
| Mar 2010 | - | $247.22M(-1.0%) |
| Dec 2009 | $249.77M(-17.0%) | $249.77M(-1.7%) |
| Sep 2009 | - | $254.10M(-5.8%) |
| Jun 2009 | - | $269.64M(-3.7%) |
| Mar 2009 | - | $279.87M(-7.0%) |
| Dec 2008 | $301.00M(-0.5%) | $301.00M(-41.3%) |
| Sep 2008 | - | $512.51M(+2.3%) |
| Jun 2008 | - | $500.77M(+65.4%) |
| Mar 2008 | - | $302.84M(+0.1%) |
| Dec 2007 | $302.53M(+16.7%) | $302.53M(+4.2%) |
| Sep 2007 | - | $290.37M(+7.7%) |
| Jun 2007 | - | $269.68M(+9.5%) |
| Mar 2007 | - | $246.29M(-5.0%) |
| Dec 2006 | $259.33M(-16.7%) | $259.33M(+2.3%) |
| Sep 2006 | - | $253.58M(-7.8%) |
| Jun 2006 | - | $275.12M(+2.6%) |
| Mar 2006 | - | $268.02M(-13.9%) |
| Dec 2005 | $311.41M(-10.8%) | $311.41M(-2.1%) |
| Sep 2005 | - | $318.25M(+0.6%) |
| Jun 2005 | - | $316.22M(-2.9%) |
| Mar 2005 | - | $325.76M(-6.7%) |
| Dec 2004 | $349.12M(+205.3%) | $349.12M(+156.6%) |
| Sep 2004 | - | $136.07M(+11.2%) |
| Jun 2004 | - | $122.36M(+10.5%) |
| Mar 2004 | - | $110.71M(-3.2%) |
| Dec 2003 | $114.35M(+0.9%) | $114.35M(+3.4%) |
| Sep 2003 | - | $110.56M(+7.3%) |
| Jun 2003 | - | $103.07M(-0.6%) |
| Mar 2003 | - | $103.66M(-8.6%) |
| Dec 2002 | $113.37M(+15.1%) | $113.37M(+12.4%) |
| Sep 2002 | - | $100.90M(-1.4%) |
| Jun 2002 | - | $102.38M(+14.1%) |
| Mar 2002 | - | $89.69M(-9.0%) |
| Dec 2001 | $98.53M(+53.2%) | $98.53M(+13.7%) |
| Sep 2001 | - | $86.63M(+7.7%) |
| Jun 2001 | - | $80.46M(-19.0%) |
| Mar 2001 | - | $99.30M(+54.4%) |
| Dec 2000 | $64.32M(+4.7%) | $64.32M(+6.2%) |
| Sep 2000 | - | $60.55M(-9.7%) |
| Jun 2000 | - | $67.08M(-20.1%) |
| Mar 2000 | - | $83.92M |
| Dec 1999 | $61.42M(-1.5%) | - |
| Dec 1998 | $62.39M | - |
FAQ
- What is Charles River Laboratories International annual total current liabilities?
- What is the all time high annual current liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International annual current liabilities year-on-year change?
- What is Charles River Laboratories International quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly current liabilities year-on-year change?
What is Charles River Laboratories International annual total current liabilities?
The current annual current liabilities of CRL is $994.10M
What is the all time high annual current liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high annual total current liabilities is $1.09B
What is Charles River Laboratories International annual current liabilities year-on-year change?
Over the past year, CRL annual total current liabilities has changed by -$60.98M (-5.78%)
What is Charles River Laboratories International quarterly total current liabilities?
The current quarterly current liabilities of CRL is $1.05B
What is the all time high quarterly current liabilities for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly total current liabilities is $1.09B
What is Charles River Laboratories International quarterly current liabilities year-on-year change?
Over the past year, CRL quarterly total current liabilities has changed by +$96.25M (+10.08%)